Search Results 51-60 of 16626 for GLP-1 alternatives

  1. Michael D. Jensen, M.D. - Mayo Clinic Faculty Profiles

    Whether a person gains or loses fat in one ... Jensen's team hopes to provide insights into potential new therapeutic options to prevent and treat insulin ...

  2. Caffeine: Does it affect blood sugar? - Mayo Clinic

    Click here for an email preview. Email. Address 1 ... Diabetes foods: Can I substitute honey for sugar? ... Podcast: How do GLP-1s work? See also. 10 great ...

  3. Cholesterol medications: Consider the options - Mayo Clinic

    1, 2020. Rosenson RS. Low density lipoprotein cholesterol lowering with drugs other than statins and PCSK9 inhibitors. https://www.uptodate.com/contents/search.

  4. Dietary supplements for weight loss - Mayo Clinic

    Type 3 or more letters to display suggested search options. ... The sellers of raspberry ketone base that claim on one ... The trial assigned them at random to one ...

  5. Intermittent fasting: What are the benefits? - Mayo Clinic

    Fasting for a set time is one way people limit calories. What's the appeal and what are the risks ... Type 3 or more letters to display suggested search options.

  6. Insulin degludec and liraglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Angioedema (swelling of the face, lips, tongue, throat, arms, or legs) caused by GLP-1 receptor agonists, history of—Use with caution. May increase the risk ...

  7. Complex bariatric surgery for high-risk patients and revision of past procedures - Mayo Clinic

    Despite the increased demand for glucagon-like peptide-1 receptor agonists (GLP ... Mayo Clinic has published one ... Surgery options for patients with severe ...

  8. Publications - Ryan J. Solinsky, M.D. - Mayo Clinic

    Type 3 or more letters to display suggested search options. ... GLP-1 receptor agonists as pharmacological ... 2024 Jan 1; 326 (1):H116-H122 Epub 2023 Nov 10

  9. Study Evaluating The Safety And Efficacy Of Semaglutide, And The Fixed-Dose Combination Of Cilofexor And Firsocostat, Alone And In Combination, In Participants With Compensated Cirrhosis (F4) Due To Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    - History of type 1 diabetes. - Treatment with a glucagon-like peptide-1 receptor agonist (GLP-1 RA) in the period from 90 days prior to the screening visit ...

  10. Pivotal Aspiration Therapy With Adjusted Lifestyle Therapy Study - Mayo Clinic

    ... 1 trial. Phase 4 trials ... Failed attempt for a duration equal to 3-months at weight loss by alternative ... Taking a GLP-1 agonist < 6 months. Taking ...